Network Pharmacology and In Vivo Evaluation of Modified Huanglian Wendan Decoction in Polycystic Ovary Syndrome With Insulin Resistance: Association With AGE–RAGE‐Related Signaling

Xi Chen, Xing Yang, Xinni Wang, Dan Chou, Chenghong Zheng · 2026

Read Network Pharmacology and In Vivo Evaluation of Modified Huanglian Wendan Decoction in Polycystic Ovary Syndrome With Insulin Resistance: Association With AGE–RAGE‐Related Signaling by Xi Chen, Xing Yang, Xinni Wang, Dan Chou, Chenghong Zheng (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13626855.txt.

Description

Xi Chen and colleagues put a traditional Chinese herbal formula under a modern lens for polycystic ovary syndrome paired with insulin resistance. The modified Huanglian Wendan decoction is used clinically, yet its working parts were murky. The team combined network pharmacology, molecule docking, and motion simulations with chemical fingerprinting of the brew. Then they fed the brew to rats made to mimic the condition. A hormone drug and a fatty diet did the mimicking.

Treated rats recovered regular cycles and healthier ovaries, while fasting insulin, hormone levels, and inflammation markers all fell. Fingerprinting found hundreds of candidate compounds, and network math pointed at a sugar-damage pathway, AGE-RAGE, with two relay proteins moving as predicted. The authors stress the pathway link is an association, not proof of cause, in a multi-ingredient medicine.

Catalog record

CREATORXi Chen, Xing Yang, Xinni Wang, Dan Chou, Chenghong Zheng
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE34 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13626855

Browse the full library · About the Tower of Babel